Lipid metabolism reprogramming in endometrial cancer: biological functions and therapeutic implications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Lipid metabolism reprogramming in endometrial cancer: biological functions and therapeutic implications ; volume:22 ; number:1 ; day:10 ; month:9 ; year:2024 ; pages:1-19 ; date:12.2024
Cell communication and signaling ; 22, Heft 1 (10.9.2024), 1-19, 12.2024
- Creator
-
Wang, Xiangyu
Li, Yinuo
Hou, Xin
Li, Jingfang
Ma, Xiangyi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-024-01792-7
- URN
-
urn:nbn:de:101:1-2411242102559.055896609613
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Xiangyu
- Li, Yinuo
- Hou, Xin
- Li, Jingfang
- Ma, Xiangyi
- SpringerLink (Online service)
Other Objects (12)
Etiological relationship between lipid metabolism and endometrial carcinoma
Lipid metabolism reprogramming and its potential targets in cancer
Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy
Lipid metabolism in tumor microenvironment: novel therapeutic targets
THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer
Genetic and therapeutic aspects of lipid and purine metabolism
The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma
Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy
Dietary restriction protects from age-associated DNA methylation and induces epigenetic reprogramming of lipid metabolism
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance
Plant lipid metabolism
Etiological relationship between lipid metabolism and endometrial carcinoma
Lipid metabolism reprogramming and its potential targets in cancer
Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy
Lipid metabolism in tumor microenvironment: novel therapeutic targets
THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer
Genetic and therapeutic aspects of lipid and purine metabolism
The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma
Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy
Dietary restriction protects from age-associated DNA methylation and induces epigenetic reprogramming of lipid metabolism
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance
Plant lipid metabolism
Etiological relationship between lipid metabolism and endometrial carcinoma
Lipid metabolism reprogramming and its potential targets in cancer
Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy
Lipid metabolism in tumor microenvironment: novel therapeutic targets
THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer
Genetic and therapeutic aspects of lipid and purine metabolism
The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma
Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy
Dietary restriction protects from age-associated DNA methylation and induces epigenetic reprogramming of lipid metabolism
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance